person in white dress shirt holding brown wooden chopsticks

The Dieting Industry Has Been Selling You the Same Thing for a Hundred Years

The US weight loss market hit $135 billion in 2025. It got there by finding a very reliable customer and never actually solving their problem.

Max Stephens

7/28/20265 min read

The US weight loss market hit a historic peak of $135 billion in 2025. That number didn't arrive overnight; It was built over a century of products, programs, and promises, each one finding an audience, producing results for some people, and cycling those people back into the market when the results didn't last.

The industry's most reliable customer isn't someone who fails at dieting. It's someone who succeeds at it, stops, and needs to start again. The cycle rather than the failure is what keeps the numbers growing.

Where this actually started

The first commercial diet pill reached American shelves in the 1920s. A product called Marmola contained desiccated thyroid hormones, which accelerated metabolism and produced weight loss. It worked. It also caused heart palpitations, and people died from it.

Fast results with consequences figured out later has been the playbook ever since.

The mid-20th century diet landscape was a mix of amphetamine-based appetite suppressants, heavily restrictive calorie protocols, and the early foundations of what would become the commercial diet program industry. The FDA pulled various products from shelves repeatedly as health consequences emerged that hadn't been studied before widespread use.

Weight Watchers and the age of accountability

Weight Watchers launched in 1963. The founder started hosting informal accountability meetings in her Queens apartment, inviting neighbors to talk about food, habits, and progress. It spread through word of mouth and eventually became one of the most recognized diet brands in the world.

By the 2010s, the company's financials were closely watched as a barometer of American diet culture. In 2015, Oprah Winfrey purchased a 10 percent stake in the company for $43 million. When the news broke, the stock surged dramatically and Oprah ultimately made approximately $400 million from that investment. That transaction alone illustrated how much cultural weight, and financial weight, the diet industry was carrying by the mid-2010s.

Weight Watchers rebranded as WW in 2018, pivoting its messaging from weight loss to overall wellness. That rebranding reflected a broader shift in how diet companies were positioning themselves as the cultural conversation around wellness became more nuanced and the word diet started carrying negative connotations.

Atkins and the low-carb explosion

The Atkins diet was first introduced by Dr. Robert Atkins in 1972, but it exploded into mainstream culture in the early 2000s in a way that few diet trends ever have.

The protocol was straightforward. Drastically restrict carbohydrate intake and increase fat and protein consumption, pushing the body into an alternative metabolic state.

At its peak, one in eleven Americans was reported to be on the Atkins diet. The brand was generating over $100 million annually in product sales on top of book sales that had already made it one of the bestselling diet books in history. Entire restaurant chains modified their menus to accommodate low-carb demand. The food industry responded with a wave of low-carb product lines.

Then the practical reality of sustaining that kind of carbohydrate restriction long-term caught up with adoption rates. Bread is everywhere. So is pasta. The protocol worked for many people while they were on it. Staying on it indefinitely proved harder than the initial enthusiasm suggested.

The meal replacement era

Slim Fast, Jenny Craig, and NutriSystem defined the 1980s and 1990s diet market with a model that was essentially the same across all three brands.

Replace real food with a proprietary product. Structure your intake around that product. Buy it on a recurring basis.

It was a subscription model before subscription models had a name. The product was the solution and the solution required ongoing purchase to keep working.

Jenny Craig at its peak was generating over $400 million in annual revenue. NutriSystem reached similar heights. Both built their businesses on the understanding that many people find the simplicity of replacing food decisions with a pre-made system useful in the short term, and both were structured in ways that created long-term dependency on the product rather than developing the habits that would have made the product unnecessary.

Keto

The ketogenic diet is low-carb eating taken further and given a better brand story.

The goal is to shift the body into ketosis, a metabolic state where it burns fat for fuel rather than carbohydrates. Achieving and maintaining ketosis requires keeping carbohydrate intake extremely low, typically under 50 grams per day.

The keto market hit $9.57 billion in 2019. The internet amplified it in ways that previous low-carb waves couldn't match. Bulletproof coffee and macro tracking apps built around keto ratios proliferated. Ketone testing became a minor industry of its own.

A significant portion of the weight lost in the early weeks of a ketogenic diet is water weight, a consequence of the body depleting glycogen stores which hold water. Many people do lose additional weight beyond that, and the research on keto for certain metabolic conditions is solid. But it's also a demanding protocol that requires significant ongoing dietary restriction, and many people find it difficult to maintain strictly over a long period of time. The diet continues to have devoted adherents, but the wave of mass adoption that peaked around 2019 has settled into a smaller and more committed base.

The injectable era

Then came something different altogether. This time it's not a diet or meal plan. Injectable weight loss medications that suppress hunger at a neurological level entered the mainstream conversation and changed the market in ways that older diet programs haven't fully adjusted to.

The US weight loss market reached $135 billion in 2025 largely because of these medications. They work. The clinical data is robust. But they're also prescription drugs with real side effects, and the weight tends to come back when people stop taking them, which raises questions about what long-term use looks like and positions these drugs as the diet industry's most consistent customer acquisition tool yet.

Commercial diet companies including WW, NutriSystem, and Jenny Craig have all had to respond to a market where a medically prescribed drug is now the dominant weight loss intervention for many consumers. Jenny Craig shut down entirely in 2023. NutriSystem has restructured. WW is promoting GLP-1's. The programs that built the industry on meal plans and accountability meetings are navigating a moment where the intervention that actually moves the needle for many people comes from a prescription pad rather than a point system.

Why the cycle keeps running

The diet industry is profitable because our food environment and overconsumption makes staying lean relatively difficult, and because the companies selling solutions have no financial incentive to give you one that actually works permanently.

A customer who loses weight and keeps it off forever without buying anything is a lost customer. The business model works best when the solution is temporary and the customer returns.

The food industry that makes staying lean hard and the diet industry that sells solutions to the problem it partially created are not separate ecosystems. Many of the same holding companies have interests in both. The processed food that makes weight management difficult and the diet product that promises to address the consequences of eating it are sometimes owned by the same parent company. It's a business structure that happens to produce a very reliable demand cycle.

The way out

The way out of the cycle isn't a new diet trend with a catchy commercial.

The research on long-term weight management is consistent and has been for decades. Eating food that isn't heavily processed, moving your body regularly, sleeping adequately, managing stress, and building a life where those things are the choices you actually want to make.

That's not a satisfying answer for an industry that needs to sell something. But it's what the evidence has supported for a long time, and it's what tends to separate the people who get off the diet cycle from the people who stay on it.

The $135 billion market will keep growing. The injectables will evolve. New programs will launch with new frameworks. The customer the industry depends on most will keep arriving, because the conditions that create that customer aren't being addressed by any of the products being sold to them.

That's not a failure of willpower. It's a feature of the system.

Want articles like this one delivered weekly? Join the newsletter and get a quick recap of everything we cover, straight to your inbox, once a week.